Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered 1.4 Market Analysis by Type 1.4.1 Global Indolent Lymphoma Treatment Market Size Growth Rate by Type (2014-2025) 1.4.2 BI-836826 1.4.3 ALT-803 1.4.4 BMS-986016 1.4.5 CC-122 1.4.6 Others 1.5 Market by Application 1.5.1 Global Indolent Lymphoma Treatment Market Share by Application (2014-2025) 1.5.2 Hospital 1.5.3 Clinic 1.5.4 Others 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends 2.1 Indolent Lymphoma Treatment Market Size 2.2 Indolent Lymphoma Treatment Growth Trends by Regions 2.2.1 Indolent Lymphoma Treatment Market Size by Regions (2014-2025) 2.2.2 Indolent Lymphoma Treatment Market Share by Regions (2014-2019) 2.3 Industry Trends 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Opportunities 3 Market Share by Key Players 3.1 Indolent Lymphoma Treatment Market Size by Manufacturers 3.1.1 Global Indolent Lymphoma Treatment Revenue by Manufacturers (2014-2019) 3.1.2 Global Indolent Lymphoma Treatment Revenue Market Share by Manufacturers (2014-2019) 3.1.3 Global Indolent Lymphoma Treatment Market Concentration Ratio (CR5 and HHI) 3.2 Indolent Lymphoma Treatment Key Players Head office and Area Served 3.3 Key Players Indolent Lymphoma Treatment Product/Solution/Service 3.4 Date of Enter into Indolent Lymphoma Treatment Market 3.5 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type and Application 4.1 Global Indolent Lymphoma Treatment Market Size by Type (2014-2019) 4.2 Global Indolent Lymphoma Treatment Market Size by Application (2014-2019) 5 United States 5.1 United States Indolent Lymphoma Treatment Market Size (2014-2019) 5.2 Indolent Lymphoma Treatment Key Players in United States 5.3 United States Indolent Lymphoma Treatment Market Size by Type 5.4 United States Indolent Lymphoma Treatment Market Size by Application 6 Europe 6.1 Europe Indolent Lymphoma Treatment Market Size (2014-2019) 6.2 Indolent Lymphoma Treatment Key Players in Europe 6.3 Europe Indolent Lymphoma Treatment Market Size by Type 6.4 Europe Indolent Lymphoma Treatment Market Size by Application 7 China 7.1 China Indolent Lymphoma Treatment Market Size (2014-2019) 7.2 Indolent Lymphoma Treatment Key Players in China 7.3 China Indolent Lymphoma Treatment Market Size by Type 7.4 China Indolent Lymphoma Treatment Market Size by Application 8 Japan 8.1 Japan Indolent Lymphoma Treatment Market Size (2014-2019) 8.2 Indolent Lymphoma Treatment Key Players in Japan 8.3 Japan Indolent Lymphoma Treatment Market Size by Type 8.4 Japan Indolent Lymphoma Treatment Market Size by Application 9 Southeast Asia 9.1 Southeast Asia Indolent Lymphoma Treatment Market Size (2014-2019) 9.2 Indolent Lymphoma Treatment Key Players in Southeast Asia 9.3 Southeast Asia Indolent Lymphoma Treatment Market Size by Type 9.4 Southeast Asia Indolent Lymphoma Treatment Market Size by Application 10 India 10.1 India Indolent Lymphoma Treatment Market Size (2014-2019) 10.2 Indolent Lymphoma Treatment Key Players in India 10.3 India Indolent Lymphoma Treatment Market Size by Type 10.4 India Indolent Lymphoma Treatment Market Size by Application 11 Central & South America 11.1 Central & South America Indolent Lymphoma Treatment Market Size (2014-2019) 11.2 Indolent Lymphoma Treatment Key Players in Central & South America 11.3 Central & South America Indolent Lymphoma Treatment Market Size by Type 11.4 Central & South America Indolent Lymphoma Treatment Market Size by Application 12 International Players Profiles 12.1 Altor BioScience Corporation 12.1.1 Altor BioScience Corporation Company Details 12.1.2 Company Description and Business Overview 12.1.3 Indolent Lymphoma Treatment Introduction 12.1.4 Altor BioScience Corporation Revenue in Indolent Lymphoma Treatment Business (2014-2019) 12.1.5 Altor BioScience Corporation Recent Development 12.2 Amgen Inc. 12.2.1 Amgen Inc. Company Details 12.2.2 Company Description and Business Overview 12.2.3 Indolent Lymphoma Treatment Introduction 12.2.4 Amgen Inc. Revenue in Indolent Lymphoma Treatment Business (2014-2019) 12.2.5 Amgen Inc. Recent Development 12.3 Astellas Pharma Inc. 12.3.1 Astellas Pharma Inc. Company Details 12.3.2 Company Description and Business Overview 12.3.3 Indolent Lymphoma Treatment Introduction 12.3.4 Astellas Pharma Inc. Revenue in Indolent Lymphoma Treatment Business (2014-2019) 12.3.5 Astellas Pharma Inc. Recent Development 12.4 Bayer AG 12.4.1 Bayer AG Company Details 12.4.2 Company Description and Business Overview 12.4.3 Indolent Lymphoma Treatment Introduction 12.4.4 Bayer AG Revenue in Indolent Lymphoma Treatment Business (2014-2019) 12.4.5 Bayer AG Recent Development 12.5 Boehringer Ingelheim GmbH 12.5.1 Boehringer Ingelheim GmbH Company Details 12.5.2 Company Description and Business Overview 12.5.3 Indolent Lymphoma Treatment Introduction 12.5.4 Boehringer Ingelheim GmbH Revenue in Indolent Lymphoma Treatment Business (2014-2019) 12.5.5 Boehringer Ingelheim GmbH Recent Development 12.6 Bristol-Myers Squibb Company 12.6.1 Bristol-Myers Squibb Company Company Details 12.6.2 Company Description and Business Overview 12.6.3 Indolent Lymphoma Treatment Introduction 12.6.4 Bristol-Myers Squibb Company Revenue in Indolent Lymphoma Treatment Business (2014-2019) 12.6.5 Bristol-Myers Squibb Company Recent Development 12.7 Celgene Corporation 12.7.1 Celgene Corporation Company Details 12.7.2 Company Description and Business Overview 12.7.3 Indolent Lymphoma Treatment Introduction 12.7.4 Celgene Corporation Revenue in Indolent Lymphoma Treatment Business (2014-2019) 12.7.5 Celgene Corporation Recent Development 12.8 Eli Lilly and Company 12.8.1 Eli Lilly and Company Company Details 12.8.2 Company Description and Business Overview 12.8.3 Indolent Lymphoma Treatment Introduction 12.8.4 Eli Lilly and Company Revenue in Indolent Lymphoma Treatment Business (2014-2019) 12.8.5 Eli Lilly and Company Recent Development 12.9 F. Hoffmann-La Roche Ltd. 12.9.1 F. Hoffmann-La Roche Ltd. Company Details 12.9.2 Company Description and Business Overview 12.9.3 Indolent Lymphoma Treatment Introduction 12.9.4 F. Hoffmann-La Roche Ltd. Revenue in Indolent Lymphoma Treatment Business (2014-2019) 12.9.5 F. Hoffmann-La Roche Ltd. Recent Development 12.10 Gilead Sciences 12.10.1 Gilead Sciences Company Details 12.10.2 Company Description and Business Overview 12.10.3 Indolent Lymphoma Treatment Introduction 12.10.4 Gilead Sciences Revenue in Indolent Lymphoma Treatment Business (2014-2019) 12.10.5 Gilead Sciences Recent Development 12.11 Incyte Corporation 12.12 Infinity Pharmaceuticals 12.13 Juno Therapeutics Inc. 12.14 MedImmune 13 Market Forecast 2019-2025 13.1 Market Size Forecast by Regions 13.2 United States 13.3 Europe 13.4 China 13.5 Japan 13.6 Southeast Asia 13.7 India 13.8 Central & South America 13.9 Market Size Forecast by Product (2019-2025) 13.10 Market Size Forecast by Application (2019-2025) 14 Analyst's Viewpoints/Conclusions 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.1.1 Research Programs/Design 15.1.1.2 Market Size Estimation 12.1.1.3 Market Breakdown and Data Triangulation 15.1.2 Data Source 15.1.2.1 Secondary Sources 15.1.2.2 Primary Sources 15.2 Disclaimer 15.3 Author Details

List of Tables and Figures Table Indolent Lymphoma Treatment Key Market Segments Table Key Players Indolent Lymphoma Treatment Covered Table Global Indolent Lymphoma Treatment Market Size Growth Rate by Type 2014-2025 (Million US$) Figure Global Indolent Lymphoma Treatment Market Size Market Share by Type 2014-2025 Figure BI-836826 Figures Table Key Players of BI-836826 Figure ALT-803 Figures Table Key Players of ALT-803 Figure BMS-986016 Figures Table Key Players of BMS-986016 Figure CC-122 Figures Table Key Players of CC-122 Figure Others Figures Table Key Players of Others Table Global Indolent Lymphoma Treatment Market Size Growth by Application 2014-2025 (Million US$) Figure Hospital Case Studies Figure Clinic Case Studies Figure Others Case Studies Figure Indolent Lymphoma Treatment Report Years Considered Table Global Indolent Lymphoma Treatment Market Size 2014-2025 (Million US$) Figure Global Indolent Lymphoma Treatment Market Size and Growth Rate 2014-2025 (Million US$) Table Global Indolent Lymphoma Treatment Market Size by Regions 2014-2025 (Million US$) Table Global Indolent Lymphoma Treatment Market Size by Regions 2014-2019 (Million US$) Table Global Indolent Lymphoma Treatment Market Share by Regions 2014-2019 Figure Global Indolent Lymphoma Treatment Market Share by Regions 2014-2019 Figure Global Indolent Lymphoma Treatment Market Share by Regions 2019 Table Market Top Trends Table Global Indolent Lymphoma Treatment Revenue by Manufacturers (2014-2019) (Million US$) Table Global Indolent Lymphoma Treatment Market Share by Manufacturers (2014-2019) Figure Global Indolent Lymphoma Treatment Market Share by Manufacturers in 2018 Table Global Indolent Lymphoma Treatment Manufacturers Market Concentration Ratio (CR5 and HHI) Table Key Players Head office and Area Served Table Key Players Indolent Lymphoma Treatment Product/Solution/Service Table Date of Enter into Indolent Lymphoma Treatment Market Table Mergers & Acquisitions, Expansion Plans Table Global Indolent Lymphoma Treatment Market Size by Type (2014-2019) (Million US$) Table Global Indolent Lymphoma Treatment Market Size Share by Type (2014-2019) Figure Global Indolent Lymphoma Treatment Market Size Market Share by Type (2014-2019) Table Global Indolent Lymphoma Treatment Market Size by Application (2014-2019) (Million US$) Table Global Indolent Lymphoma Treatment Market Size Share by Application (2014-2019) Figure Global Indolent Lymphoma Treatment Market Size Market Share by Application (2014-2019) Figure Global Indolent Lymphoma Treatment Revenue Market Share by Application in 2018 Figure United States Indolent Lymphoma Treatment Market Size 2014-2019 (Million US$) Table United States Key Players Indolent Lymphoma Treatment Revenue (2018-2019) (Million US$) Table United States Key Players Indolent Lymphoma Treatment Market Share (2018-2019) Table United States Indolent Lymphoma Treatment Market Size by Type (2014-2019) (Million US$) Table United States Indolent Lymphoma Treatment Market Share by Type (2014-2019) Table United States Indolent Lymphoma Treatment Market Size by Application (2014-2019) (Million US$) Table United States Indolent Lymphoma Treatment Market Share by Application (2014-2019) Figure Europe Indolent Lymphoma Treatment Market Size 2014-2019 (Million US$) Table Europe Key Players Indolent Lymphoma Treatment Revenue (2018-2019) (Million US$) Table Europe Key Players Indolent Lymphoma Treatment Market Share (2018-2019) Table Europe Indolent Lymphoma Treatment Market Size by Type (2014-2019) (Million US$) Table Europe Indolent Lymphoma Treatment Market Share by Type (2014-2019) Table Europe Indolent Lymphoma Treatment Market Size by Application (2014-2019) (Million US$) Table Europe Indolent Lymphoma Treatment Market Share by Application (2014-2019) Figure China Indolent Lymphoma Treatment Market Size 2014-2019 (Million US$) Table China Key Players Indolent Lymphoma Treatment Revenue (2018-2019) (Million US$) Table China Key Players Indolent Lymphoma Treatment Market Share (2018-2019) Table China Indolent Lymphoma Treatment Market Size by Type (2014-20189) (Million US$) Table China Indolent Lymphoma Treatment Market Share by Type (2014-2019) Table China Indolent Lymphoma Treatment Market Size by Application (2014-2019) (Million US$) Table China Indolent Lymphoma Treatment Market Share by Application (2014-2019) Figure Japan Indolent Lymphoma Treatment Market Size 2014-2019 (Million US$) Table Japan Key Players Indolent Lymphoma Treatment Revenue (2018-2019) (Million US$) Table Japan Key Players Indolent Lymphoma Treatment Market Share (2018-2019) Table Japan Indolent Lymphoma Treatment Market Size by Type (2014-2019) (Million US$) Table Japan Indolent Lymphoma Treatment Market Share by Type (2014-2019) Table Japan Indolent Lymphoma Treatment Market Size by Application (2014-2019) (Million US$) Table Japan Indolent Lymphoma Treatment Market Share by Application (2014-2019) Figure Southeast Asia Indolent Lymphoma Treatment Market Size 2014-2019 (Million US$) Table Southeast Asia Key Players Indolent Lymphoma Treatment Revenue (2018-2019) (Million US$) Table Southeast Asia Key Players Indolent Lymphoma Treatment Market Share (2018-2019) Table Southeast Asia Indolent Lymphoma Treatment Market Size by Type (2014-2019) (Million US$) Table Southeast Asia Indolent Lymphoma Treatment Market Share by Type (2014-2019) Table Southeast Asia Indolent Lymphoma Treatment Market Size by Application (2014-2019) (Million US$) Table Southeast Asia Indolent Lymphoma Treatment Market Share by Application (2014-2019) Figure India Indolent Lymphoma Treatment Market Size 2014-2019 (Million US$) Table India Key Players Indolent Lymphoma Treatment Revenue (2018-2019) (Million US$) Table India Key Players Indolent Lymphoma Treatment Market Share (2018-2019) Table India Indolent Lymphoma Treatment Market Size by Type (2014-2019) (Million US$) Table India Indolent Lymphoma Treatment Market Share by Type (2014-2019) Table India Indolent Lymphoma Treatment Market Size by Application (2014-2019) (Million US$) Table India Indolent Lymphoma Treatment Market Share by Application (2014-2019) Figure Central & South America Indolent Lymphoma Treatment Market Size 2014-2019 (Million US$) Table Central & South America Key Players Indolent Lymphoma Treatment Revenue (2018-2019) (Million US$) Table Central & South America Key Players Indolent Lymphoma Treatment Market Share (2018-2019) Table Central & South America Indolent Lymphoma Treatment Market Size by Type (2014-2019) (Million US$) Table Central & South America Indolent Lymphoma Treatment Market Share by Type (2014-2019) Table Central & South America Indolent Lymphoma Treatment Market Size by Application (2014-2019) (Million US$) Table Central & South America Indolent Lymphoma Treatment Market Share by Application (2014-2019) Table Altor BioScience Corporation Company Details Table Altor BioScience Corporation Revenue in Indolent Lymphoma Treatment Business (2014-2019) (Million US$) Figure Altor BioScience Corporation Revenue Growth Rate in Indolent Lymphoma Treatment Business (2014-2019) Table Altor BioScience Corporation Recent Development Table Amgen Inc. Company Details Table Amgen Inc. Revenue in Indolent Lymphoma Treatment Business (2014-2019)(Million US$) Figure Amgen Inc. Revenue Growth Rate in Indolent Lymphoma Treatment Business (2014-2019) Table Amgen Inc. Recent Development Table Astellas Pharma Inc. Company Details Table Astellas Pharma Inc. Revenue in Indolent Lymphoma Treatment Business (2014-2019)(Million US$) Figure Astellas Pharma Inc. Revenue Growth Rate in Indolent Lymphoma Treatment Business (2014-2019) Table Astellas Pharma Inc. Recent Development Table Bayer AG Company Details Table Bayer AG Revenue in Indolent Lymphoma Treatment Business (2014-2019)(Million US$) Figure Bayer AG Revenue Growth Rate in Indolent Lymphoma Treatment Business (2014-2019) Table Bayer AG Recent Development Table Boehringer Ingelheim GmbH Company Details Table Boehringer Ingelheim GmbH Revenue in Indolent Lymphoma Treatment Business (2014-2019)(Million US$) Figure Boehringer Ingelheim GmbH Revenue Growth Rate in Indolent Lymphoma Treatment Business (2014-2019) Table Boehringer Ingelheim GmbH Recent Development Table Bristol-Myers Squibb Company Company Details Table Bristol-Myers Squibb Company Revenue in Indolent Lymphoma Treatment Business (2014-2019)(Million US$) Figure Bristol-Myers Squibb Company Revenue Growth Rate in Indolent Lymphoma Treatment Business (2014-2019) Table Bristol-Myers Squibb Company Recent Development Table Celgene Corporation Company Details Table Celgene Corporation Revenue in Indolent Lymphoma Treatment Business (2014-2019)(Million US$) Figure Celgene Corporation Revenue Growth Rate in Indolent Lymphoma Treatment Business (2014-2019) Table Celgene Corporation Recent Development Table Eli Lilly and Company Company Details Table Eli Lilly and Company Revenue in Indolent Lymphoma Treatment Business (2014-2019)(Million US$) Figure Eli Lilly and Company Revenue Growth Rate in Indolent Lymphoma Treatment Business (2014-2019) Table Eli Lilly and Company Recent Development Table F. Hoffmann-La Roche Ltd. Company Details Table F. Hoffmann-La Roche Ltd. Revenue in Indolent Lymphoma Treatment Business (2014-2019)(Million US$) Figure F. Hoffmann-La Roche Ltd. Revenue Growth Rate in Indolent Lymphoma Treatment Business (2014-2019) Table F. Hoffmann-La Roche Ltd. Recent Development Table Gilead Sciences Company Details Table Gilead Sciences Revenue in Indolent Lymphoma Treatment Business (2014-2019)(Million US$) Figure Gilead Sciences Revenue Growth Rate in Indolent Lymphoma Treatment Business (2014-2019) Table Gilead Sciences Recent Development Table Incyte Corporation Company Details Table Infinity Pharmaceuticals Company Details Table Juno Therapeutics Inc. Company Details Table MedImmune Company Details Table Global Indolent Lymphoma Treatment Market Size by Regions (Million US$) 2019-2025 Figure Global Indolent Lymphoma Treatment Market Size Share by Regions (2019-2025) Figure Global Indolent Lymphoma Treatment Market Size Share by Regions in 2025 Figure United States Indolent Lymphoma Treatment Market Size Forecast (2019-2025)(Million USD) Figure Europe Indolent Lymphoma Treatment Market Size Forecast (2019-2025)(Million USD) Figure China Indolent Lymphoma Treatment Market Size Forecast (2019-2025)(Million USD) Figure Japan Indolent Lymphoma Treatment Market Size Forecast (2019-2025)(Million USD) Figure Southeast Asia Indolent Lymphoma Treatment Market Size Forecast (2019-2025)(Million USD) Figure India Indolent Lymphoma Treatment Market Size Forecast (2019-2025)(Million USD) Figure Central & South America Indolent Lymphoma Treatment Market Size Forecast (2019-2025)(Million USD) Table Global Indolent Lymphoma Treatment Market Size by Product (2019-2025) (Million US$) Figure Global Indolent Lymphoma Treatment Market Size by Product (2019-2025) Figure Global Indolent Lymphoma Treatment Market Size by Product in 2025 Table Global Indolent Lymphoma Treatment Market Size by Application (2019-2025) (Million US$) Figure Global Indolent Lymphoma Treatment Market Size by Application (2019-2025) Figure Global Indolent Lymphoma Treatment Market Size by Application in 2025 Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

Altor BioScience Corporation Amgen Inc. Astellas Pharma Inc. Bayer AG Boehringer Ingelheim GmbH Bristol-Myers Squibb Company Celgene Corporation Eli Lilly and Company F. Hoffmann-La Roche Ltd. Gilead Sciences Incyte Corporation Infinity Pharmaceuticals Juno Therapeutics Inc. MedImmune